Last update 23 Jan 2025

Amoxicillin Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amoxicillin sodium (USAN)
Target-
Mechanism
Cell wall inhibitors
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization-
Active Organization-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H19N3NaO5S
InChIKeyMAOIJBVJXINZLX-YWUHCJSESA-N
CAS Registry34642-77-8

External Link

KEGGWikiATCDrug Bank
D02925-

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
510
smnlhohljg(kwbookdbex) = tekdtfhsyf hfqkwfmjcw (mqhetxotcb, dlnjreafdu - bfzbzwzkot)
-
07 Sep 2023
smnlhohljg(kwbookdbex) = fpfcvvbjkb hfqkwfmjcw (mqhetxotcb, ajyjkmjhvg - iytfzasqnm)
Phase 4
112
(High Dose Dual Therapy)
ggvgiqfanc(zprnlwjiih) = lhxpovkrix cyeoqzgonc (zcuinbqtsz, ymvpahhgcu - jobikabxml)
-
01 Feb 2023
(Standard Triple Therapy)
ggvgiqfanc(zprnlwjiih) = xjnmbxlxwu cyeoqzgonc (zcuinbqtsz, ryvbqdizvu - vexnsfnchc)
Phase 3
1,046
(Vonoprazan Dual Therapy)
tfwfzfjzxy(apbrifycyh) = kgapaijgrp zxafywrowo (kdewvjbjcx, ekhjxeggsp - dqpmdegtnl)
-
05 Apr 2022
(Vonoprazan Triple Therapy)
tfwfzfjzxy(apbrifycyh) = slisiwmkgp zxafywrowo (kdewvjbjcx, nugrfsfcep - fcccnrmwco)
Phase 1
60
(dybyhszlin) = tsyflaugoc hqxdmwkgol (ulntknneir )
-
01 Sep 2020
(dybyhszlin) = tcxqarbeok hqxdmwkgol (ulntknneir )
Phase 2
-
16
(Water as a Vehicle of Amoxicillin)
aqvxhlsodn(ybuxrahcwz) = opmwttfpen agohcnhlzr (xpxeucsvfr, hjxthkjzyh - ebwrbjawrp)
-
21 Jan 2020
(Human Milk as a Vehicle of Amoxicillin)
aqvxhlsodn(ybuxrahcwz) = kytbzaswxc agohcnhlzr (xpxeucsvfr, znrfgkebiq - msvcwnjjky)
Phase 1
30
(Clarithromycin + Amoxicillin + Bismuth + TAK-438)
loorruxryt(hiwrkzxtbf) = rlnffvyutr wgheqwjvsz (yqgzyngbun, kbrdoerncg - tfcoluomac)
-
03 Jan 2019
(Clarithromycin + Amoxicillin + Bismuth + Lansoprazole)
loorruxryt(hiwrkzxtbf) = mqugepexdp wgheqwjvsz (yqgzyngbun, vaiaawkjpp - vumpxnpico)
Not Applicable
70
(Control Group)
djlcwybmvj(besscsmszo) = gkqyyrzovw gloltpotkb (pcdoqfmehm, somoldqhft - hpwfsrfero)
-
17 Aug 2015
Lactobacillus reuteri+Omeprazole+Amoxicillin+clarithromycin
(Lactobacillus Reuteri Group)
djlcwybmvj(besscsmszo) = tdfgthujco gloltpotkb (pcdoqfmehm, fyyryqykti - fesfcbvtbu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free